Brief introduction of Brasilia pharmaceutical co., ltd.

Brasilia Pharmaceutical Co., Ltd. is a multinational pharmaceutical company headquartered in Switzerland. On June 5-438 10, 2000, Roche Pharmaceutical, an international pharmaceutical giant, split some senior managers and R&D scientists from its headquarters in Basel, Switzerland, and established Bathelia Pharmaceutical Company independently. Roche Pharmaceuticals is still one of the three major shareholders of Bathelia. In March 2004, Brasilia Pharmaceutical Company was listed on the Swiss Stock Exchange. As an emerging pharmaceutical company completely driven by new drug research and development, the company has an original drug listed in 19 countries around the world; In addition, two original new drugs have completed phase III clinical studies in the United States and the European Union, and are awaiting the approval of the FDA. In addition, the company also has a number of original new drugs in pre-clinical and phase I and phase II clinical research.